RXST RxSight Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: RXST

Price (delayed)

$4.85

Market cap

$201.73M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.13

Enterprise value

$198.21M

?
Relative Growth: Rel. Growth: 28
Relative Strength: Rel. Strength: 13
Relative Valuation: Rel. Valuation: 22
Relative Profitability: Rel. Profitability: 28

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light ...

Highlights
RxSight's debt has decreased by 10% YoY and by 2.3% from the previous quarter
RxSight's gross margin has increased by 6% YoY
RxSight's quick ratio has plunged by 72% YoY and by 59% from the previous quarter
RXST's net income is down by 46% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: https://www.rxsight.com

Key stats

What are the main financial stats of RXST

RXST stock price

How has the RxSight stock price performed over time
Intraday
-1.62%
1 week
-10.19%
1 month
-22.4%
1 year
-48.73%
YTD
-53.45%
QTD
0.62%

Financial performance

How have RxSight's revenue and profit performed over time
Revenue
$127.58M
Gross profit
$98.87M
Operating income
-$55.11M
Net income
-$46.95M
Gross margin
77.5%
Net margin
-36.8%
RxSight's net margin has plunged by 68% YoY
The company's operating margin fell by 49% YoY
RXST's net income is down by 46% year-on-year
The operating income has decreased by 30% YoY

Price vs fundamentals

How does RXST's price correlate with its fundamentals

Growth

What is RxSight's growth rate over time

Valuation

What is RxSight stock price valuation
P/E
N/A
P/B
0.76
P/S
1.58
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.55
The EPS has declined by 41% year-on-year
RXST's P/B is 82% below its 5-year quarterly average of 4.3 and 30% below its last 4 quarters average of 1.1
RXST's equity is down by 5% year-on-year
RXST's P/S is 84% below its 5-year quarterly average of 9.7 and 30% below its last 4 quarters average of 2.3
RXST's revenue is down by 13% year-on-year

Efficiency

How efficient is RxSight business performance
The return on sales has dropped by 68% year-on-year
RXST's ROE has shrunk by 50% YoY and by 2.4% QoQ
RxSight's return on invested capital has decreased by 48% YoY
The ROA has decreased by 43% YoY but it has increased by 2.6% from the previous quarter

Dividends

What is RXST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RXST.

Financial health

How did RxSight financials performed over time
The company's total liabilities has surged by 188% YoY and by 144% QoQ
RxSight's quick ratio has plunged by 72% YoY and by 59% from the previous quarter
RxSight's debt is 96% less than its equity
RxSight's debt has decreased by 10% YoY and by 2.3% from the previous quarter
RXST's equity is down by 5% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.